These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11459455)

  • 1. Immunological properties of uricase conjugated to neutral soluble polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 2001; 12(4):515-22. PubMed ID: 11459455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 1999; 10(4):638-46. PubMed ID: 10411462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).
    Schiavon O; Caliceti P; Ferruti P; Veronese FM
    Farmaco; 2000 Apr; 55(4):264-9. PubMed ID: 10966157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.
    Tsuji J; Hirose K; Kasahara E; Naitoh M; Yamamoto I
    Int J Immunopharmacol; 1985; 7(5):725-30. PubMed ID: 2412977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins.
    Caliceti P; Veronese FM; Jonak Z
    Farmaco; 1999 Jul; 54(7):430-7. PubMed ID: 10486910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tolerance in mice by uricase and monomethoxypolyethylene glycol-modified uricase.
    Savoca KV; Davis FF; Palczuk NC
    Int Arch Allergy Appl Immunol; 1984; 75(1):58-67. PubMed ID: 6746105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biopharmaceutical properties of PEGylated uricase.
    Freitas Dda S; Spencer PJ; Vassão RC; Abrahão-Neto J
    Int J Pharm; 2010 Mar; 387(1-2):215-22. PubMed ID: 19969053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.
    Ozer I; Kelly G; Gu R; Li X; Zakharov N; Sirohi P; Nair SK; Collier JH; Hershfield MS; Hucknall AM; Chilkoti A
    Adv Sci (Weinh); 2022 Apr; 9(11):e2103672. PubMed ID: 35133079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
    Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
    Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of modification of a bacterial uricase with N-hydroxysuccinimide esters of succinate and carbonate of monomethoxyl poly(ethylene glycol).
    Zhang C; Yang X; Gao A; Hu X; Pu J; Liu H; Feng J; Liao J; Li Y; Liao F
    Biotechnol Appl Biochem; 2014; 61(6):683-90. PubMed ID: 24512141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.
    Saifer MG; Williams LD; Sobczyk MA; Michaels SJ; Sherman MR
    Mol Immunol; 2014 Feb; 57(2):236-46. PubMed ID: 24200843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol).
    Chen RH; Abuchowski A; Van Es T; Palczuk NC; Davis FF
    Biochim Biophys Acta; 1981 Aug; 660(2):293-8. PubMed ID: 7197160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.
    Nishimura H; Matsushima A; Inada Y
    Enzyme; 1981; 26(1):49-53. PubMed ID: 7194181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.
    Nishimura H; Ashihara Y; Matsushima A; Inada Y
    Enzyme; 1979; 24(4):261-4. PubMed ID: 573687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
    Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
    Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
    Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA
    J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates.
    Salmaso S; Semenzato A; Bersania S; Chinol M; Paganelli G; Caliceti P
    Biochim Biophys Acta; 2005 Oct; 1726(1):57-66. PubMed ID: 15964691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of modification of amino groups with poly(ethylene glycol) on a recombinant uricase from Bacillus fastidiosus.
    Zhang C; Yang X; Feng J; Yuan Y; Li X; Bu Y; Xie Y; Yuan H; Liao F
    Biosci Biotechnol Biochem; 2010; 74(6):1298-301. PubMed ID: 20530883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypouricaemic effect after oral administration in chickens of polyethylene glycol-modified uricase entrapped in liposomes.
    Nishida Y; Kamatani N; Miyamoto T
    J Pharm Pharmacol; 1984 May; 36(5):354-5. PubMed ID: 6145782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.
    Yasuda Y; Fujita T; Takakura Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2053-6. PubMed ID: 1702692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.